| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.005 |